Government to Buy 200M More Vaccine Doses
Headline Roundup January 26th, 2021
President Joe Biden announced plans Tuesday to purchase 200 million more COVID-19 vaccine doses, attempting to guarantee vaccination for at least 300 million Americans by the fall. Biden's administration will buy 100 million doses each of the Pfizer-BioNTech vaccine and the Moderna vaccine, raising the current U.S. supply to about 600 million doses (both vaccine variants require two doses). Biden also explained plans to boost weekly vaccine distribution to states, and to better coordinate the allocations.
Coverage was similar throughout the political spectrum. Neither side of the media seemed to adopt a biased narrative around the announcement.
The Biden administration announced Tuesday that it is working to purchase an additional 200 million doses of the two coronavirus vaccines that have been authorized for emergency use in the United States.
The administration hopes to have enough vaccine supply for almost the entire U.S. population by the end of summer.
The purchase of 100 million doses each of Moderna and Pfizer’s vaccines would grow the available supply by 50 percent to a total of 600 million doses by summer — enough to fully vaccinate 300 million people as both...
President Joe Biden announced Tuesday the U.S. has reached an agreement to purchase an additional 200 million coronavirus vaccine doses, a boost that means the U.S. will have enough supply to fully vaccinate 300 million Americans by the end of summer or beginning of fall..
"This is a wartime undertaking. It's not hyperbole," Biden said during remarks on the COVID-19 pandemic at the White House.
Biden outlined the new purchase plans along with an increase in the weekly vaccine allocation to states, tribes and territories from 8.6 million doses to...
The Biden administration on Tuesday announced that the federal government intends to purchase 200 million additional doses of two federally approved COVID-19 vaccines, potentially creating a stock large enough to reach nearly the entire U.S. population.
The U.S. has already purchased 400 million shots from manufacturers Pfizer and Moderna, both of which use a novel mRNA vaccine that has proven highly effective in trials but that also requires two doses, spaced weeks apart. With the extra shots that the Biden administration intends to purchase, there would, in theory, be enough...